The S&P 500 slid 0.1% on Thursday, Aug. 7, 2025, as new tariffs took effect, raising import duties on goods from numerous U.S. trading partners.

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

New experimental oral weight loss drug, Orforglipron, helped participants lose up to 14.7% of body weight in a Phase 3 trial, ...

GLP-1's, which are traditionally diabetes medications, have exploded in popularity since they were approved for weight-loss.

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

Adjusted Despite Literally Everything," the Disney alum reveals they underwent an “extreme regimen” for a 'Hunger Games' role ...

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

Plus, studies show that a high-protein diet can help with losing fat and gaining muscle at the same time. Research shows that ...